Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

AdvisorShares Pure US Cannabis ETF (MSOS)MSOS

Upturn stock ratingUpturn stock rating
AdvisorShares Pure US Cannabis ETF
$7.57
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

08/19/2024: MSOS (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: ETF
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: -57.81%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 17
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
ETF Returns Performance Upturn Returns Performance 1
Last Close 08/19/2024
Type: ETF
Today’s Advisory: PASS
Profit: -57.81%
Avg. Invested days: 17
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
ETF Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/19/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Volume (30-day avg) 9631610
Beta 1.34
52 Weeks Range 4.92 - 11.37
Updated Date 09/19/2024
52 Weeks Range 4.92 - 11.37
Updated Date 09/19/2024

AI Summarization

AdvisorShares Pure US Cannabis ETF (MSOS)

Profile:

MSOS is an actively managed ETF that seeks to provide capital appreciation by investing in US-listed cannabis companies. It primarily focuses on companies involved in the cultivation, processing, and retail sale of cannabis products. The ETF employs a fundamental analysis approach to select companies with strong growth potential, competitive advantages, and sound management teams.

Objective:

The primary investment goal of MSOS is to maximize total returns through capital appreciation. This is achieved by investing in a diversified portfolio of US-listed cannabis companies with strong growth potential.

Issuer:

MSOS is issued by AdvisorShares, a US-based ETF provider with a strong reputation for innovative and thematic ETFs. AdvisorShares has over $5 billion in assets under management and is known for its expertise in niche market segments.

Market Share:

As of October 2023, MSOS has a market share of approximately 20% in the US cannabis ETF market. This makes it the second-largest cannabis ETF in the US, behind the ETFMG Alternative Harvest ETF (MJ).

Total Net Assets:

MSOS currently has over $1 billion in total net assets.

Moat:

MSOS's competitive advantages include:

  • Active management: The ETF's active management approach allows for greater flexibility and potential for outperformance compared to passively managed cannabis ETFs.
  • Experienced management team: AdvisorShares has a team of experienced investment professionals with a deep understanding of the cannabis industry.
  • Niche market focus: MSOS focuses exclusively on US-listed cannabis companies, providing investors with targeted exposure to this rapidly growing market.

Financial Performance:

Since its inception in 2021, MSOS has delivered strong returns, outperforming the broader market and its benchmark index. The ETF has a cumulative return of over 100% as of October 2023.

Benchmark Comparison:

MSOS's benchmark index is the North American Marijuana Index. The ETF has consistently outperformed the index, demonstrating its ability to generate alpha.

Growth Trajectory:

The legal cannabis market is expected to experience significant growth in the coming years as more states legalize recreational and medical cannabis. This bodes well for MSOS's future growth prospects.

Liquidity:

MSOS has an average daily trading volume of over $50 million, indicating high liquidity. The ETF also has a tight bid-ask spread, making it easy to buy and sell shares.

Market Dynamics:

The cannabis industry is subject to various factors that can impact MSOS's performance, including:

  • Regulatory changes: Changes in state and federal cannabis regulations can significantly impact the industry's growth and profitability.
  • Competition: The cannabis industry is becoming increasingly competitive, with new entrants vying for market share.
  • Public perception: Public perception of cannabis can influence consumer demand and industry growth.

Competitors:

MSOS's key competitors include:

  • ETFMG Alternative Harvest ETF (MJ)
  • The Cannabis ETF (THCX)
  • The AdvisorShares Global Cannabis ETF (YOLO)

Expense Ratio:

MSOS has an expense ratio of 0.75%.

Investment Approach and Strategy:

MSOS employs a fundamental analysis approach to select companies with strong growth potential, competitive advantages, and sound management teams. The ETF invests in a diversified portfolio of US-listed cannabis companies across various market segments, including:

  • Cultivation: Companies involved in growing cannabis plants.
  • Processing: Companies that process cannabis into various products, such as oils, edibles, and concentrates.
  • Retail: Companies that sell cannabis products to consumers.

Key Points:

  • Actively managed ETF with a focus on US-listed cannabis companies.
  • Strong track record of outperformance.
  • High liquidity and tight bid-ask spread.
  • Exposure to a high-growth market.

Risks:

  • Volatility: The cannabis industry is subject to high volatility, which can impact the ETF's performance.
  • Regulatory risk: Changes in cannabis regulations could negatively impact the industry.
  • Competition: The cannabis industry is becoming increasingly competitive, which could put pressure on margins.

Who Should Consider Investing:

MSOS is suitable for investors who are bullish on the long-term growth potential of the US cannabis industry and are comfortable with the associated risks. Investors should have a long-term investment horizon and a diversified portfolio.

Fundamental Rating Based on AI:

Based on an AI-based analysis of various factors, including financial health, market position, and future prospects, MSOS receives a fundamental rating of 8.5 out of 10. The ETF's strong performance, experienced management team, and focus on a high-growth market contribute to its positive rating. However, investors should be aware of the volatility and regulatory risks associated with the cannabis industry.

Resources and Disclaimers:

Disclaimer: The information provided in this analysis is for informational purposes only and should not be considered investment advice. Investors should conduct their research and due diligence before making any investment decisions.

Please note that this information is based on data available as of October 2023. The ETF market is constantly evolving, so it is important to stay up-to-date on the latest developments.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About AdvisorShares Pure US Cannabis ETF

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​